Interfacial and distal-heme pocket mutations exhibit additive effects on the structure and function of hemoglobin.
Protein engineering strategies seek to develop a hemoglobin-based oxygen carrier with optimized functional properties, including (i) an appropriate O 2 affinity, (ii) high cooperativity, (iii) limited NO reactivity, and (iv) a diminished rate of auto-oxidation. The mutations alphaL29F, alphaL29W, alphaV96W and betaN108K individually impart some of these traits and in combinations produce hemoglobin molecules with interesting ligand-binding and allosteric properties. Studies of the ligand-binding properties and solution structures of single and multiple mutants have been performed. The aromatic side chains placed in the distal-heme pocket environment affect the intrinsic ligand-binding properties of the mutated subunit itself, beyond what can be explained by allostery, and these changes are accompanied by local structural perturbations. In contrast, hemoglobins with mutations in the alpha 1beta 1 and alpha 1beta 2 interfaces display functional properties of both "R"- and "T"-state tetramers because the equilibrium between quaternary states is altered. These mutations are accompanied by global structural perturbations, suggesting an indirect, allostery-driven cause for their effects. Combinations of the distal-heme pocket and interfacial mutations exhibit additive effects in both structural and functional properties, contribute to our understanding of allostery, and advance protein-engineering methods for manipulating the O 2 binding properties of the hemoglobin molecule.
Maillett
David H
DH
Department of Biological Sciences, Carnegie Mellon University, Pittsburgh, Pennsylvania 15213, USA.
Simplaceanu
Virgil
V
Shen
Tong-Jian
TJ
Ho
Nancy T
NT
Olson
John S
JS
Ho
Chien
C
D006418:Heme / Q000737:chemistry*; D006454:Hemoglobins / Q000737:chemistry* / Q000235:genetics / Q000378:metabolism; D006801:Humans; D007700:Kinetics; D009154:Mutation; D010100:Oxygen / Q000378:metabolism; D011485:Protein Binding; D011994:Recombinant Proteins / Q000737:chemistry* / Q000378:metabolism
D006454:Hemoglobins; D011994:Recombinant Proteins; D006418:Heme; D010100:Oxygen
J Protein Chem. 2003 Apr;22(3):221-30
12962322
Biochemistry. 1996 Jun 4;35(22):6976-83
8679521
J Biol Chem. 1989 Oct 5;264(28):16573-83
2777799
Biophys J. 2000 Aug;79(2):1146-54
10920044
J Biol Chem. 1987 Sep 25;262(27):12930-8
3654596
Biochemistry. 2000 Nov 14;39(45):13708-18
11076510
J Mol Biol. 2006 Jul 14;360(3):690-701
16765986
Nat Struct Biol. 1997 Jan;4(1):78-83
8989328
Biophys Chem. 2002 Jul 10;98(1-2):127-48
12128195
Biochemistry. 2001 Oct 16;40(41):12357-68
11591155
Methods Enzymol. 1981;76:631-51
7329281
J Mol Biol. 1995 May 12;248(4):867-82
7752247
Methods Enzymol. 1994;232:363-86
8057869
Biochemistry. 1998 Jun 30;37(26):9258-65
9649306
Proc Natl Acad Sci U S A. 2003 Jan 21;100(2):517-20
12525687
Biochemistry. 2006 Apr 25;45(16):5140-8
16618103
Protein Sci. 2001 Nov;10(11):2401-7
11604545
J Biol Chem. 1992 Jul 15;267(20):14443-50
1629229
Biochemistry. 1992 Nov 17;31(45):11182-95
1445857
Biochemistry. 1999 Oct 5;38(40):13433-42
10529220
J Biol Chem. 1992 Aug 25;267(24):17248-56
1512262
FEBS Lett. 2001 Mar 9;492(1-2):50-3
11248235
Biochemistry. 2005 Jun 14;44(23):8347-59
15938624
Proc Natl Acad Sci U S A. 1994 Nov 8;91(23):11113-7
7972019
J Am Chem Soc. 2002 Jul 3;124(26):7646-7
12083904
J Cereb Blood Flow Metab. 1988 Jun;8(3):403-10
3130382
Biochemistry. 1999 Jul 6;38(27):8751-61
10393550
J Biomol NMR. 2004 Dec;30(4):423-9
15630562
Biochemistry. 2005 May 17;44(19):7207-17
15882059
Proc Natl Acad Sci U S A. 1993 Sep 1;90(17):8108-12
8367471
FEBS Lett. 1978 Aug 1;92(1):53-6
668922
Biochemistry. 1985 Jul 2;24(14):3398-407
4041419
Biophys Chem. 2002 Jul 10;98(1-2):79-91
12128191
Methods Mol Med. 2003;82:65-91
12669638
Biophys Chem. 2007 Jun;128(1):63-74
17418478
Proc Natl Acad Sci U S A. 1988 Apr;85(7):2151-5
3353372
Biochemistry. 2004 Sep 28;43(38):12048-64
15379545
Biophys Chem. 2002 Jul 10;98(1-2):149-64
12128196
Biochemistry. 1999 Apr 20;38(16):5191-9
10213626
Biochemistry. 1979 Nov 13;18(23):5238-47
497180
Structure. 1997 Feb 15;5(2):227-37
9032082
Protein Eng. 1997 Sep;10(9):1085-97
9464574
Annu Rev Biophys Biomol Struct. 1998;27:1-34
9646860
Biochemistry. 2004 Sep 28;43(38):12065-80
15379546
J Biol Chem. 1998 Sep 4;273(36):23150-9
9722544
Nature. 1992 Mar 19;356(6366):258-60
1552945
Biochemistry. 2006 Mar 7;45(9):2820-35
16503637
J Biol Chem. 2002 Sep 13;277(37):34508-20
12107163
Biochemistry. 1975 Jun 3;14(11):2526-35
1138870
Nat Biotechnol. 1998 Jul;16(7):672-6
9661203
Annu Rev Biomed Eng. 2006;8:289-321
16834558
Microvasc Res. 1998 Sep;56(2):113-26
9756734
Free Radic Biol Med. 2004 Mar 15;36(6):685-97
14990349
J Mol Biol. 1965 May;12:88-118
14343300
Biochemistry. 1995 Nov 14;34(45):14658-67
7578073
Biochemistry. 2007 Sep 4;46(35):9973-80
17691822
Cardiovasc Res. 1996 Oct;32(4):632-43
8915182
Biophys Chem. 2002 Jul 10;98(1-2):15-25
12128186
Methods Enzymol. 1978;48:270-99
345049